Burrows Francis — SEC Form 4 filings

SEC reporting owner CIK 2051119. 5 Form 4 filings on record with FilingPulse; latest filed 2026-01-27.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2025-01-07 to 2026-01-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Kura Oncology, Inc. (KURA)Chief Scientific Officer54 legs · 27,203 sh · $260,0744

Form 4 filings — Burrows Francis

FiledFormIssuerReported transactionsSource
2026-01-274Kura Oncology, Inc. (KURA)Sale (S): 1,311 @ $8.46EDGAR
2026-01-064Kura Oncology, Inc. (KURA)Grant/award (A): 185,000 (derivative) @ $0EDGAR
2025-12-194Kura Oncology, Inc. (KURA)Option exercise (M): 35,000 @ $4.80 · Sale (S): 23,726 @ $9.78 · Option exercise (M): 35,000 (derivative) @ $0EDGAR
2025-01-284Kura Oncology, Inc. (KURA)Sale (S): 846 @ $7.87 · Sale (S): 1,320 @ $7.87EDGAR
2025-01-074Kura Oncology, Inc. (KURA)Grant/award (A): 185,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2051119 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →